Home > > > > > Report Detail

Global Celecoxib Market Research Report 2022 Professional Edition

Publisher Name :
Date: 07-Jan-2022
No. of pages: 138

The global Celecoxib market was valued at 1158.64 Million USD in 2021 and will grow with a CAGR of 8.91% from 2021 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs. Data show that more than 400 million people worldwide are currently affected by joint diseases. The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75. The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing. At present, the burden of chronic diseases will increase by 40% due to the aging of the population. As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth. Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice. At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years. At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly. It accounted for 63.39% of the global market in 2019. As of 2019, China relies entirely on Pfizer for celecoxib imports. Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.

By Market Verdors:

Pfizer Inc

Teva

Mylan

Apotex

Lupin

Hengrui Medicine

By Types:

50mg

100mg

200mg

400mg

By Applications:

Rheumatoid arthritis

osteoarthritis

Acute pain

Musculoskeletal pain

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements

Global Celecoxib Market Research Report 2022 Professional Edition

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Celecoxib Revenue
1.4 Market Analysis by Type
1.4.1 Global Celecoxib Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 50mg
1.4.3 100mg
1.4.4 200mg
1.4.5 400mg
1.5 Market by Application
1.5.1 Global Celecoxib Market Share by Application: 2022-2027
1.5.2 Rheumatoid arthritis
1.5.3 osteoarthritis
1.5.4 Acute pain
1.5.5 Musculoskeletal pain
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Celecoxib Market
1.8.1 Global Celecoxib Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Celecoxib Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Celecoxib Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Celecoxib Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Celecoxib Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Celecoxib Sales Volume Market Share by Region (2016-2021)
3.2 Global Celecoxib Sales Revenue Market Share by Region (2016-2021)
3.3 North America Celecoxib Sales Volume
3.3.1 North America Celecoxib Sales Volume Growth Rate (2016-2021)
3.3.2 North America Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Celecoxib Sales Volume
3.4.1 East Asia Celecoxib Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Celecoxib Sales Volume (2016-2021)
3.5.1 Europe Celecoxib Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Celecoxib Sales Volume (2016-2021)
3.6.1 South Asia Celecoxib Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Celecoxib Sales Volume (2016-2021)
3.7.1 Southeast Asia Celecoxib Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Celecoxib Sales Volume (2016-2021)
3.8.1 Middle East Celecoxib Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Celecoxib Sales Volume (2016-2021)
3.9.1 Africa Celecoxib Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Celecoxib Sales Volume (2016-2021)
3.10.1 Oceania Celecoxib Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Celecoxib Sales Volume (2016-2021)
3.11.1 South America Celecoxib Sales Volume Growth Rate (2016-2021)
3.11.2 South America Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Celecoxib Sales Volume (2016-2021)
3.12.1 Rest of the World Celecoxib Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Celecoxib Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Celecoxib Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Celecoxib Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Celecoxib Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Celecoxib Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Celecoxib Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Celecoxib Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Celecoxib Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Celecoxib Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Celecoxib Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Celecoxib Sales Volume Market Share by Type (2016-2021)
14.2 Global Celecoxib Sales Revenue Market Share by Type (2016-2021)
14.3 Global Celecoxib Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Celecoxib Consumption Volume by Application (2016-2021)
15.2 Global Celecoxib Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Celecoxib Business
16.1 Pfizer Inc
16.1.1 Pfizer Inc Company Profile
16.1.2 Pfizer Inc Celecoxib Product Specification
16.1.3 Pfizer Inc Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Teva
16.2.1 Teva Company Profile
16.2.2 Teva Celecoxib Product Specification
16.2.3 Teva Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Mylan
16.3.1 Mylan Company Profile
16.3.2 Mylan Celecoxib Product Specification
16.3.3 Mylan Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Apotex
16.4.1 Apotex Company Profile
16.4.2 Apotex Celecoxib Product Specification
16.4.3 Apotex Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Lupin
16.5.1 Lupin Company Profile
16.5.2 Lupin Celecoxib Product Specification
16.5.3 Lupin Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Hengrui Medicine
16.6.1 Hengrui Medicine Company Profile
16.6.2 Hengrui Medicine Celecoxib Product Specification
16.6.3 Hengrui Medicine Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Celecoxib Manufacturing Cost Analysis
17.1 Celecoxib Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Celecoxib
17.4 Celecoxib Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Celecoxib Distributors List
18.3 Celecoxib Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Celecoxib (2022-2027)
20.2 Global Forecasted Revenue of Celecoxib (2022-2027)
20.3 Global Forecasted Price of Celecoxib (2016-2027)
20.4 Global Forecasted Production of Celecoxib by Region (2022-2027)
20.4.1 North America Celecoxib Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Celecoxib Production, Revenue Forecast (2022-2027)
20.4.3 Europe Celecoxib Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Celecoxib Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Celecoxib Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Celecoxib Production, Revenue Forecast (2022-2027)
20.4.7 Africa Celecoxib Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Celecoxib Production, Revenue Forecast (2022-2027)
20.4.9 South America Celecoxib Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Celecoxib Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Celecoxib by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Celecoxib by Country
21.2 East Asia Market Forecasted Consumption of Celecoxib by Country
21.3 Europe Market Forecasted Consumption of Celecoxib by Countriy
21.4 South Asia Forecasted Consumption of Celecoxib by Country
21.5 Southeast Asia Forecasted Consumption of Celecoxib by Country
21.6 Middle East Forecasted Consumption of Celecoxib by Country
21.7 Africa Forecasted Consumption of Celecoxib by Country
21.8 Oceania Forecasted Consumption of Celecoxib by Country
21.9 South America Forecasted Consumption of Celecoxib by Country
21.10 Rest of the world Forecasted Consumption of Celecoxib by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

List of Tables and Figures

Key Players Covered: Ranking by Celecoxib Revenue (US$ Million) 2016-2021
Global Celecoxib Market Size by Type (US$ Million): 2022-2027
Global Celecoxib Market Size by Application (US$ Million): 2022-2027
Global Celecoxib Production Capacity by Manufacturers
Global Celecoxib Production by Manufacturers (2016-2021)
Global Celecoxib Production Market Share by Manufacturers (2016-2021)
Global Celecoxib Revenue by Manufacturers (2016-2021)
Global Celecoxib Revenue Share by Manufacturers (2016-2021)
Global Market Celecoxib Average Price of Key Manufacturers (2016-2021)
Manufacturers Celecoxib Production Sites and Area Served
Manufacturers Celecoxib Product Type
Global Celecoxib Sales Volume by Region (2016-2021)
Global Celecoxib Sales Volume Market Share by Region (2016-2021)
Global Celecoxib Sales Revenue by Region (2016-2021)
Global Celecoxib Sales Revenue Market Share by Region (2016-2021)
North America Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Celecoxib Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Celecoxib Consumption by Countries (2016-2021)
East Asia Celecoxib Consumption by Countries (2016-2021)
Europe Celecoxib Consumption by Region (2016-2021)
South Asia Celecoxib Consumption by Countries (2016-2021)
Southeast Asia Celecoxib Consumption by Countries (2016-2021)
Middle East Celecoxib Consumption by Countries (2016-2021)
Africa Celecoxib Consumption by Countries (2016-2021)
Oceania Celecoxib Consumption by Countries (2016-2021)
South America Celecoxib Consumption by Countries (2016-2021)
Rest of the World Celecoxib Consumption by Countries (2016-2021)
Global Celecoxib Sales Volume by Type (2016-2021)
Global Celecoxib Sales Volume Market Share by Type (2016-2021)
Global Celecoxib Sales Revenue by Type (2016-2021)
Global Celecoxib Sales Revenue Share by Type (2016-2021)
Global Celecoxib Sales Price by Type (2016-2021)
Global Celecoxib Consumption Volume by Application (2016-2021)
Global Celecoxib Consumption Volume Market Share by Application (2016-2021)
Global Celecoxib Consumption Value by Application (2016-2021)
Global Celecoxib Consumption Value Market Share by Application (2016-2021)
Pfizer Inc Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Teva Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Mylan Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table Apotex Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Lupin Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Hengrui Medicine Celecoxib Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Celecoxib Distributors List
Celecoxib Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Celecoxib Production Forecast by Region (2022-2027)
Global Celecoxib Sales Volume Forecast by Type (2022-2027)
Global Celecoxib Sales Volume Market Share Forecast by Type (2022-2027)
Global Celecoxib Sales Revenue Forecast by Type (2022-2027)
Global Celecoxib Sales Revenue Market Share Forecast by Type (2022-2027)
Global Celecoxib Sales Price Forecast by Type (2022-2027)
Global Celecoxib Consumption Volume Forecast by Application (2022-2027)
Global Celecoxib Consumption Value Forecast by Application (2022-2027)
North America Celecoxib Consumption Forecast 2022-2027 by Country
East Asia Celecoxib Consumption Forecast 2022-2027 by Country
Europe Celecoxib Consumption Forecast 2022-2027 by Country
South Asia Celecoxib Consumption Forecast 2022-2027 by Country
Southeast Asia Celecoxib Consumption Forecast 2022-2027 by Country
Middle East Celecoxib Consumption Forecast 2022-2027 by Country
Africa Celecoxib Consumption Forecast 2022-2027 by Country
Oceania Celecoxib Consumption Forecast 2022-2027 by Country
South America Celecoxib Consumption Forecast 2022-2027 by Country
Rest of the world Celecoxib Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources


Global Celecoxib Market Share by Type: 2021 VS 2027
50mg Features
100mg Features
200mg Features
400mg Features
Global Celecoxib Market Share by Application: 2021 VS 2027
Rheumatoid arthritis Case Studies
osteoarthritis Case Studies
Acute pain Case Studies
Musculoskeletal pain Case Studies
Celecoxib Report Years Considered
Global Celecoxib Market Status and Outlook (2016-2027)
North America Celecoxib Revenue (Value) and Growth Rate (2016-2027)
East Asia Celecoxib Revenue (Value) and Growth Rate (2016-2027)
Europe Celecoxib Revenue (Value) and Growth Rate (2016-2027)
South Asia Celecoxib Revenue (Value) and Growth Rate (2016-2027)
South America Celecoxib Revenue (Value) and Growth Rate (2016-2027)
Middle East Celecoxib Revenue (Value) and Growth Rate (2016-2027)
Africa Celecoxib Revenue (Value) and Growth Rate (2016-2027)
Oceania Celecoxib Revenue (Value) and Growth Rate (2016-2027)
South America Celecoxib Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Celecoxib Revenue (Value) and Growth Rate (2016-2027)
North America Celecoxib Sales Volume Growth Rate (2016-2021)
East Asia Celecoxib Sales Volume Growth Rate (2016-2021)
Europe Celecoxib Sales Volume Growth Rate (2016-2021)
South Asia Celecoxib Sales Volume Growth Rate (2016-2021)
Southeast Asia Celecoxib Sales Volume Growth Rate (2016-2021)
Middle East Celecoxib Sales Volume Growth Rate (2016-2021)
Africa Celecoxib Sales Volume Growth Rate (2016-2021)
Oceania Celecoxib Sales Volume Growth Rate (2016-2021)
South America Celecoxib Sales Volume Growth Rate (2016-2021)
Rest of the World Celecoxib Sales Volume Growth Rate (2016-2021)
North America Celecoxib Consumption and Growth Rate (2016-2021)
North America Celecoxib Consumption Market Share by Countries in 2021
United States Celecoxib Consumption and Growth Rate (2016-2021)
Canada Celecoxib Consumption and Growth Rate (2016-2021)
Mexico Celecoxib Consumption and Growth Rate (2016-2021)
East Asia Celecoxib Consumption and Growth Rate (2016-2021)
East Asia Celecoxib Consumption Market Share by Countries in 2021
China Celecoxib Consumption and Growth Rate (2016-2021)
Japan Celecoxib Consumption and Growth Rate (2016-2021)
South Korea Celecoxib Consumption and Growth Rate (2016-2021)
Europe Celecoxib Consumption and Growth Rate
Europe Celecoxib Consumption Market Share by Region in 2021
Germany Celecoxib Consumption and Growth Rate (2016-2021)
United Kingdom Celecoxib Consumption and Growth Rate (2016-2021)
France Celecoxib Consumption and Growth Rate (2016-2021)
Italy Celecoxib Consumption and Growth Rate (2016-2021)
Russia Celecoxib Consumption and Growth Rate (2016-2021)
Spain Celecoxib Consumption and Growth Rate (2016-2021)
Netherlands Celecoxib Consumption and Growth Rate (2016-2021)
Switzerland Celecoxib Consumption and Growth Rate (2016-2021)
Poland Celecoxib Consumption and Growth Rate (2016-2021)
South Asia Celecoxib Consumption and Growth Rate
South Asia Celecoxib Consumption Market Share by Countries in 2021
India Celecoxib Consumption and Growth Rate (2016-2021)
Pakistan Celecoxib Consumption and Growth Rate (2016-2021)
Bangladesh Celecoxib Consumption and Growth Rate (2016-2021)
Southeast Asia Celecoxib Consumption and Growth Rate
Southeast Asia Celecoxib Consumption Market Share by Countries in 2021
Indonesia Celecoxib Consumption and Growth Rate (2016-2021)
Thailand Celecoxib Consumption and Growth Rate (2016-2021)
Singapore Celecoxib Consumption and Growth Rate (2016-2021)
Malaysia Celecoxib Consumption and Growth Rate (2016-2021)
Philippines Celecoxib Consumption and Growth Rate (2016-2021)
Vietnam Celecoxib Consumption and Growth Rate (2016-2021)
Myanmar Celecoxib Consumption and Growth Rate (2016-2021)
Middle East Celecoxib Consumption and Growth Rate
Middle East Celecoxib Consumption Market Share by Countries in 2021
Turkey Celecoxib Consumption and Growth Rate (2016-2021)
Saudi Arabia Celecoxib Consumption and Growth Rate (2016-2021)
Iran Celecoxib Consumption and Growth Rate (2016-2021)
United Arab Emirates Celecoxib Consumption and Growth Rate (2016-2021)
Israel Celecoxib Consumption and Growth Rate (2016-2021)
Iraq Celecoxib Consumption and Growth Rate (2016-2021)
Qatar Celecoxib Consumption and Growth Rate (2016-2021)
Kuwait Celecoxib Consumption and Growth Rate (2016-2021)
Oman Celecoxib Consumption and Growth Rate (2016-2021)
Africa Celecoxib Consumption and Growth Rate
Africa Celecoxib Consumption Market Share by Countries in 2021
Nigeria Celecoxib Consumption and Growth Rate (2016-2021)
South Africa Celecoxib Consumption and Growth Rate (2016-2021)
Egypt Celecoxib Consumption and Growth Rate (2016-2021)
Algeria Celecoxib Consumption and Growth Rate (2016-2021)
Morocco Celecoxib Consumption and Growth Rate (2016-2021)
Oceania Celecoxib Consumption and Growth Rate
Oceania Celecoxib Consumption Market Share by Countries in 2021
Australia Celecoxib Consumption and Growth Rate (2016-2021)
New Zealand Celecoxib Consumption and Growth Rate (2016-2021)
South America Celecoxib Consumption and Growth Rate
South America Celecoxib Consumption Market Share by Countries in 2021
Brazil Celecoxib Consumption and Growth Rate (2016-2021)
Argentina Celecoxib Consumption and Growth Rate (2016-2021)
Columbia Celecoxib Consumption and Growth Rate (2016-2021)
Chile Celecoxib Consumption and Growth Rate (2016-2021)
Venezuelal Celecoxib Consumption and Growth Rate (2016-2021)
Peru Celecoxib Consumption and Growth Rate (2016-2021)
Puerto Rico Celecoxib Consumption and Growth Rate (2016-2021)
Ecuador Celecoxib Consumption and Growth Rate (2016-2021)
Rest of the World Celecoxib Consumption and Growth Rate
Rest of the World Celecoxib Consumption Market Share by Countries in 2021
Kazakhstan Celecoxib Consumption and Growth Rate (2016-2021)
Sales Market Share of Celecoxib by Type in 2021
Sales Revenue Market Share of Celecoxib by Type in 2021
Global Celecoxib Consumption Volume Market Share by Application in 2021
Pfizer Inc Celecoxib Product Specification
Teva Celecoxib Product Specification
Mylan Celecoxib Product Specification
Apotex Celecoxib Product Specification
Lupin Celecoxib Product Specification
Hengrui Medicine Celecoxib Product Specification
Manufacturing Cost Structure of Celecoxib
Manufacturing Process Analysis of Celecoxib
Celecoxib Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Celecoxib Production Capacity Growth Rate Forecast (2022-2027)
Global Celecoxib Revenue Growth Rate Forecast (2022-2027)
Global Celecoxib Price and Trend Forecast (2016-2027)
North America Celecoxib Production Growth Rate Forecast (2022-2027)
North America Celecoxib Revenue Growth Rate Forecast (2022-2027)
East Asia Celecoxib Production Growth Rate Forecast (2022-2027)
East Asia Celecoxib Revenue Growth Rate Forecast (2022-2027)
Europe Celecoxib Production Growth Rate Forecast (2022-2027)
Europe Celecoxib Revenue Growth Rate Forecast (2022-2027)
South Asia Celecoxib Production Growth Rate Forecast (2022-2027)
South Asia Celecoxib Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Celecoxib Production Growth Rate Forecast (2022-2027)
Southeast Asia Celecoxib Revenue Growth Rate Forecast (2022-2027)
Middle East Celecoxib Production Growth Rate Forecast (2022-2027)
Middle East Celecoxib Revenue Growth Rate Forecast (2022-2027)
Africa Celecoxib Production Growth Rate Forecast (2022-2027)
Africa Celecoxib Revenue Growth Rate Forecast (2022-2027)
Oceania Celecoxib Production Growth Rate Forecast (2022-2027)
Oceania Celecoxib Revenue Growth Rate Forecast (2022-2027)
South America Celecoxib Production Growth Rate Forecast (2022-2027)
South America Celecoxib Revenue Growth Rate Forecast (2022-2027)
Rest of the World Celecoxib Production Growth Rate Forecast (2022-2027)
Rest of the World Celecoxib Revenue Growth Rate Forecast (2022-2027)
North America Celecoxib Consumption Forecast 2022-2027
East Asia Celecoxib Consumption Forecast 2022-2027
Europe Celecoxib Consumption Forecast 2022-2027
South Asia Celecoxib Consumption Forecast 2022-2027
Southeast Asia Celecoxib Consumption Forecast 2022-2027
Middle East Celecoxib Consumption Forecast 2022-2027
Africa Celecoxib Consumption Forecast 2022-2027
Oceania Celecoxib Consumption Forecast 2022-2027
South America Celecoxib Consumption Forecast 2022-2027
Rest of the world Celecoxib Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report

  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs